OPEN END TURBO SHORT - RESMED | Real-time Bid/Ask 13:32:31 2024-06-27 EDT | ||
| 5.7 EUR / 5.75 EUR | -5.37% |
|
| Current month | +50.12% | ||
| 1 month | +78.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 5.49 | -9.26% |
| 24-06-26 | 6.05 | -2.42% |
| 24-06-25 | 6.2 | -3.73% |
| 24-06-24 | 6.44 | +57.84% |
| 24-06-21 | 4.08 | +19.30% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 08:42 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG3BR5 |
| ISIN | DE000MG3BR51 |
| Date issued | 2024-04-30 |
| Strike | 249.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.98 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.44 € |
|---|---|
| Lowest since issue | 2.7 € |
| Spread | 0.05 € |
| Spread % | 0.86% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
186.5
USD
Average target price
220.4
USD
Spread / Average Target
+18.17%
- Stock Market
- Certificates
- Certificat
